SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-048514
Filing Date
2022-02-22
Accepted
2022-02-22 16:05:51
Documents
18
Period of Report
2022-02-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d302710d8k.htm   iXBRL 8-K 34077
2 EX-1.1 d302710dex11.htm EX-1.1 135814
3 EX-4.2 d302710dex42.htm EX-4.2 213060
4 EX-5.1 d302710dex51.htm EX-5.1 17583
9 GRAPHIC g302710dsp15.jpg GRAPHIC 4281
10 GRAPHIC g302710dsp15a.jpg GRAPHIC 3238
  Complete submission text file 0001193125-22-048514.txt   654486

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA amgn-20220217.xsd EX-101.SCH 3908
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE amgn-20220217_def.xml EX-101.DEF 13282
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE amgn-20220217_lab.xml EX-101.LAB 21864
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amgn-20220217_pre.xml EX-101.PRE 14179
12 EXTRACTED XBRL INSTANCE DOCUMENT d302710d8k_htm.xml XML 5150
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37702 | Film No.: 22658049
SIC: 2836 Biological Products, (No Diagnostic Substances)